---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-068478"
form_type: "8-K"
ticker: "SLDB"
cik: "0001707502"
company_name: "Solid Biosciences Inc."
filed_at: "2023-03-13T23:59:59+00:00"
generated_at: "2026-06-18T04:35:53.254691+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Solid Biosciences holds less than $1M at Silicon Valley Bank; no material exposure

## Summary
- Cash balance at SVB is de minimis (<$1.0M) per March 13, 2023 filing.
- Remaining capital resources held at other institutions and money market funds.
- Disclosure follows SVB collapse; company confirms minimal direct impact.

## SEC filing metadata
- accession: 0001193125-23-068478
- form_type: 8-K
- ticker: SLDB
- cik: 0001707502
- company_name: Solid Biosciences Inc.
- filed_at: 2023-03-13T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1707502/000119312523068478/0001193125-23-068478-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1707502/000119312523068478/d467719d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-068478
- JSON: https://secwatch.observer/filing/0001193125-23-068478.json
- Plain text: https://secwatch.observer/filing/0001193125-23-068478.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.